Author:
Llorca Pierre-Michel,Lançon Christophe,Hartry Ann,Brown T. Michelle,DiBenedetti Dana B.,Kamat Siddhesh A.,François Clément
Funder
Otsuka America Pharmaceutical
Lundbeck LLC
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference28 articles.
1. Lehman AF, Lieberman JA, Dixon LB, et al. American Psychiatric Association Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1–56.
2. Barnes TR, Schizophrenia Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2011;25(5):567–620.
3. National Collaborating Centre for Mental Health. Psychosis and schizophrenia in adults: treatment and management. 2015. https://www.nice.org.uk/guidance/cg178/evidence . Accessed 1 Feb 2017.
4. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S. WFSBP task force on treatment guidelines for bipolar disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.
5. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet. 2013;381:1672–82.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献